Glycated Albumin (GA)

Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease. Glycated albumin (GA) as a potential intermediate-term glycation index to fill the gap between self-monitoring of blood glucose (SMBG) and hemoglobin A1c testing in diabetes management. The introduction gives an assessment of available short-, medium-, and long-term glycemic indicators. HbA1c is the standard measure by which to monitor long-term (2-3 months) glucose control in people with diabetes and is now used for diagnosis of diabetes. Fructosamine and glycated albumin are markers of short-term (2-4 weeks) glycaemic control that might add complementary prognostic information to HbA1c.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins NPA320Hu01 Native Glycated Albumin (GA) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies n/a Monoclonal Antibody to Glycated Albumin (GA) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Glycated Albumin (GA) Polyclonal Antibody Customized Service Offer
Assay Kits CEA320Hu ELISA Kit for Glycated Albumin (GA) Enzyme-linked immunosorbent assay for Antigen Detection.